Courses before FOCiS 2018
Courses take place before the Annual Meeting. For 2018, there will be four courses. For further information, please see the links below.
Trainee/Medical Student Member
Trainee/Medical Student Non-member
May 15-17, 2017
Aula Magna José Manuel Irarrazabal
Pontificia Universidad Católica de Chile
Avenida Bernardo O'Higgins 340
Santiago, Santiago Centro 8331010
Dr. Alexis Kalergis
Dr. Ignacio Anegon
Dr. Pablo González
FCE and regional researchers brought together in Santiago de Chile during May 15th-17th to present current scenarios and challenges in immunology. The Workshop "FOCIS goes South: Advances in Translational and Clinical Immunology" was organized by the FCE Millennium Institute on Immunology and Immunotherapy at the Pontificia Universidad Católica de Chile and gathered scientists from USA, France, Argentina, Brazil, Chile, Uruguay and Mexico, among others.
The inauguration ceremony of the Workshop was presided by the President of the Pontificia Universidad Católica de Chile, Dr. Ignacio Sánchez, the Minister of Economy, Natalia Piergentili, Senator Guido Girardi, the Director of Energy, Science, Technology and Innovation at the Ministry of Foreign Affairs, Ambassador Gabriel Rodríguez, FOCIS Multi-national FCE Chair, Dr.Ignacio Anegon, the Director of the Millennium Institute on Immunology and Immunotherapy (MIII), Dr. Alexis Kalergis, Associate Researcher at MIII and one of the organizers of the Meeting, Dr. Pablo González.
The President of UC, Ignacio Sánchez highlighted the incorporation of the MIII as a FOCIS Center of Excellence in 2016, for its advances in the development of a vaccine against the respiratory syncytial virus, personalized therapies for melanoma and prostate cancer, a herpes simplex virus vaccine and a kit for detecting infectious diseases, among other achievements. He also mentioned the contribution of this Center of Excellence on the training of young scientists and the Center's outstanding scientific productivity.
FOCIS Multi-national FCE Chair Dr. Anegon pointed out that the integrated immunology studies carried out at MIII fall within international standard.
For the Minister Piergentili, endeavors like these reflect the efforts of the Government to develop public policies that invest in science. "A decision was made 15 years ago to support the best research groups in Chile, and for this purpose the scientific Millennium initiative was created, which is harbored within the Ministry of Economy of Chile. We are sure that a country not only needs economists, but also scientists and today we are seeing that the efforts of the latter are receiving international recognition for the quality of their work", said the government authority.
For Ambassador Gabriel Rodríguez, one of the greatest challenges for science in Chile is for it to establish roots in its culture. "The Millennium Initiative is a new way of conceiving collaboration within the scientific community of different universities. The MIII is such an example, by integrating the Pontificia Universidad Católica de Chile, Universidad de Chile and Universidad Andrés Bello."
The inauguration of the international meeting concluded with the remarks of the Senator Guido Girardi, who highlighted the low investment that the country is currently performing on scientific matters, which makes it relinquish its future development. "It takes decision, will and culture to understand the world in which we are going to live in; Chile has to make a commitment towards innovation". Likewise, he appreciated the positive experience, resistance and obstinacy that researchers of the Millennium Institute have had on positioning science in the society. "
More than 350 scientists attended the meeting, with participants coming from Argentina, Brazil, Uruguay and Mexico, among other countries. Investigators from different FOCIS Centers of Excellence and Regional Research Centers presented at the Workshop sharing their latest findings to the scientific community. The activity also promoted the training of young researchers in flow cytometry with a Course on this technique.
To promote the training of young scientists in the field of immunology, the meeting was free of charge to trainees, such as undergraduates, PhD students and post-doctorates.
Information based on the article published in http://biologia.uc.cl/es/investigacion/bionoticias-investigacion/1173-instituto-milenio-de-inmunologia-e-inmunoterapia-organiza-primer-workshop-focis-en-latinoamerica by Jade Rivera Rossi, UC.
|Trainee||$0 (Free)||$0 (Free)|
Attendee is responsibile for his/her own accomodations.
The Singular +56 (2) 2306 8820 www.thesingular.com (Merced 294, Barrio Lastarria, Santiago de Chile). Price $$$
Hotel Cumbres +56 (2) 2496 9000 www.cumbreslastarria.com (Jose Victorino Lastarria299, Santiago, Chile). Price $$
Crowne Plaza +56 (2) 2638 1042 www.ihg.com (Av. Libertador Bernardo O'Higgins 136, Santiago - 6513491, Chile). Price $$
Hotel Neruda +56 (2) www.hotelneruda.cl (Av. Pedro de Valdivia 164, Providencia, Santiago - Chile). Price $
This workshop provides:
The workshop will also have expert regional speakers.
Target audience are young and experimented scientists and professionals in the field of human health, who wish to experience an update in fundamental and translational research in the field of immunology.
At the conclusion of this course, attendees will:
|9h00-10h00||Welcome Words from Academic Authorities from the Pontificia Universidad Católica de Chile, Government Authorities, Millennium Institute on Immunology and Immunotherapy, Sponsors and Organizers of the Workshop|
|Advances and Future Prospects in Immunology - Abul Abbas, MD, University of California, San Francisco, USA|
|10h30-11h00||Introduction to the Immune System|
|12h00-13h00||Antigen Presentation, T Cell Activation and Costimulation|
|14h00-15h00||CD4 T Cell Subsets, Cytokines|
|15h00-16h00||B Cells and Antibodies|
|16h00-17h00||T Cell Regulation and Tolerance I. Central and Peripheral Tolerance|
|17h30-18h00||T Cell Regulation and Tolerance II. Regulatory T Cells, Failure of Tolerance|
|8h40-8h50||Welcome words and Presentation of the Millennium Institute on Immunology and Immunotherapy, FOCIS Center of Excellence. - Dr. Alexis Kalergis, Director of the Millennium Institute on Immunology and Immunotherapy.
|8h50-9h00||Welcome words and Presentation of the Federation of Clinical Immunology Societies (FOCIS) - Dr. Abul Abbas, Member of the Board of FOCIS.|
|9h00-9h30||The Treg IL-2R as a Target for Immunotherapy - Dr. C. Garrison Fathman, Stanford University FCE, School of Medicine, USA.|
|9h30-10h00||The Intestinal Lamina Propria is a Unique Niche for Regulatory T cells - Dr. Terri Laufer, University of Pennsylvania FCE, USA.|
|10h00-10h30||Inborn Errors of FOXP3+ Regulatory T cell Development in Humans - Dr. Ciro Piccirillo, Montreal Diabetes Research Center, Montreal General Hospital, McGill, Montreal University, Canada.|
|11h00-11h30||Establishing Determinants of Human Immune Variability as a Path Towards Personalized Medical Approaches - Dr. Milena Hasan. Pasteur Institute FCE, Paris, France.|
|11h30-12h00||Phase 2 and 3 Clinical Trials of a Single Dose Virus Attenuated Tetravalent Dengue Vaccine - Dr. Jorge Kalil, University of São Paulo FCE, Brazil.|
|12h00-12h30||Unforeseen Functions for CD43 (sialophorin) - Dr. Yvonne Rosenstein, Departamento de Medicina Molecular y Bioprocesos, Universidad Autónoma de México, Cuernavaca, México|
|12h30-12h50||New and Old Drugs to Control Inflammation, Centre for Translational Immunology - Dr. Marcelo Hill, Instituto Pasteur de Montevideo, Montevideo, Uruguay|
|12h50-14h10||Lunch, poster viewing|
|14h10-14h40||Tolerogenic Dendritic Cell Therapy in Humans: Application to Kidney Transplantation - Dr. Maria Cristina Cuturi, Nantes University and INSERM FCE|
|14h40-15h00||Mucosal Inflamamtion in the Gut - Dr. Guillermo Docena, Universidad de la Plata, La Plata, Argentina|
|15h00-15h30||CD8+ Tregs in Rodent and Human Models of Organ Transplantation and GVHD - Dr. Ignacio Anegon, Nantes University And INSERM FCE.|
|15h30-16h00||Coffee break, poster viewing|
|16h00-16h30||Melanoma Cancer and Immunotherapy - Dr. Flavio Salazar, FCE Millennium Institute on Immunology and Immunotherapy, Universidad de Chile|
|16h30-17h00||Using SLE Risk Alleles to Understand Pathogenesis - Dr. Betty Diamond, The Feinstein Institute for Medical Research, Northwell Health, USA|
|17h00-17h10||Closing Words - Dr. Alexis Kalerigis, Director of the Millenium Institute on Immunology and Immunotherapy|
|9h30-17h15||Becton Dickinson Multicolor Flow Cytometry Workshop (in Spanish, limited slots available)|
|9h30-10h15||Panel Design: Best Fluorochromes for Better Results (General Public/Público General) - Paz Reyes Z. PhD, Especialista de Aplicaciones BD Chile|
|10h20-11h00||Compensation and Controls in Multicolor Flow Cytometry (General Public) - María Bernarda Ganem, PhD, Especialista de Aplicaciones BD Argentina|
|11h30-12h45||Multicolor Workshop Part I: Tools for Panel Design (Limited Spots Available)|
|14h15-15h45||Multicolor Workshop Part II: Data Analysis (Limited Spots Available)|
|16h00-17h15||General Discussion and Conclusions for the Flow Cytometer Course|
Meeting web site: www.imii.cl
Featuring faculty from several Latin American FOCIS Centers of Excellence (FCEs)
Wednesday, May 16, 2018
10:30 am – 12:30pm (symposium #12)
Dr. Guillermo Docena
Profesor Adjunto de Inmunologia
|Wednesday, May 16, 2018|
|Approaches to study and manipulate CD8+ Tregs - Dr. Ignacio Anegón (Nantes University FCE, France)|
|Modulating the immunological synapse to enhance pathogen immunity and reduce detrimental inflammation - Dr. Alexis Kalergis (Millennium Institute on Immunology and Immunotherapy FCE,)|
|Cellular aspects of graft rejection in small bowel transplantation. Clinical and animal model studies - Dr. Martín Rumbo (Universidad Nacional de La Plata FCE, Argentina)|
|A role for sialophorin (CD43) as a pathogen sensor - Dr. Yvonne Rosenstein (Universidad Nacional Autónoma de México, México)|
ALAI 2018 will be held in Cancun, Mexico, from May 14-18, 2018. Visit the below meeting websites to view the full conference program, register, submit your abstract, and learn more.
Tuesday, June 13 at FOCIS 2017
Required: In preparation for the moderated discussion, please review the following paper PRIOR to attending the course:
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. (https://www.ncbi.nlm.nih.gov/pubmed/28428369)
Clinical recovery from surgery correlates with single-cell immune signatures. (https://www.ncbi.nlm.nih.gov/pubmed/25253674)
Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. (https://www.ncbi.nlm.nih.gov/pubmed/27814509)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. (https://www.ncbi.nlm.nih.gov/pubmed/23128233)
Below please find the presentation slides. These slides will only be available online, printed handouts will not be availalbe onsite. Please note that these slides are submitted in advance by faculty members and every effort will be made to ensure the most current slides are available to attendees.
At the conclusion of this course, attendees are asked to complete an evaluation of the course and faculty. Attendee input is a crucial part of shaping the program for future years. The evaluation is required in order to receive a certificate of attendance for the course.
In the past, FOCIS has made it possible for meeting participants to obtain CME credit for attending our courses. In order to enable all those involved in the research and treatment of immune-mediated diseases to participate in the exchange of ideas that contribute to the forward motion of the field, FOCIS will not offer CME credit for the Advanced Course. Certificates of attendance will be availalbe upon request.
2013 Clinical Trials for Immunologic Disease
Sunday, June 30, 2013
Presentation Slides & Practicum Materials
Welcome & Overview - Robert Nussenblatt, MD, National Eye Institute / NIH
Key Elements of Clinical Trials - Anne Lindblad, PhD, The EMMES Corporation
Types of Clinical Trials - Robert Nussenblatt, MD, National Eye Institute, National Institutes of Health
Designing Phase I and Phase II Clinical Trials - Carla J. Greenbaum, Benaroya Research Institute
Practical Statisitical Issues in Clinical Trial Management - Darby Thompson, PhD, The EMMES Corporation
The Research Subject: Designing Feasible Trials - Carla Greenbaum, MD, Benaroya Research Institute
Biomarkers in Clinical Trials - S. Alice Long, PhD, Benaroya Research Institute
Enterting the Funding Stream: Writing and Getting Clinical Grants - Daniel Rotrosen, MD, DAIT/NIAID/NIH
Elements of Design Worksheet
Uveitis Case History